Returning 20 – 21st November 201

 Register Your Interest Now

Untitled design (8)

Thank you for attending the
2nd Dermatology Drug Development Summit

Innovating & Accelerating the
Development & Commercialization
of Dermatology Drugs

A unique industry-led conference focusing on innovating & accelerating the development & commercialization of dermatological medicines

The dermatology space continues to strive in therapeutic innovation. There’s been a transformative evolution in the understanding of the pathophysiology of skin diseases, and in the available treatment options for chronic, moderate to severe dermatological conditions that affect lives of millions of patients worldwide.

The 2nd annual Dermatology Drug Development Summit provides a unique forum for industry leaders to take advantage of this tremendous environment of opportunity driven by huge investments to innovate and bring better and more efficient drugs to market, for the treatment of high unmet need.

Leading organizations and experts in this space will share their exclusive insight in an end-to-end discussion sharing pharmaceutical best practice and the latest case-studies on the development and bringing to market of new and innovative dermatological drugs.

Join them to collaboratively tackle specific challenges you face in developing these drugs – from strategic concerns, to discovery, preclinical activities, formulation and delivery strategies, biologic therapies, clinical development, regulatory and commercial hurdles – and uncover the details behind the latest developments in this space.

View Full Event Program

View the full event program for the Dermatology Drug Development Summit with a detailed agenda, workshop details, expert speaker line-up, 25+ focused case studies and attendance breakdown

brochure 2018 - new

Key Benefits of Attending

Accelerate the development of innovative dermatological therapies

Hear from KOLs how to tackle the challenges to bring better dermatology drugs to market

Be in tune with growing excitement in the dermatology drug development space